HDAC
HDAC(组蛋白去乙酰化酶)
Histone deacetylases (HDACs), known for their ability to target histones as well as more than 50 non-histone proteins, are classified into three major classes according to their homology to yeast proteins, including class I (HDAC1, HDAC2, HDAC3 and HDAC8), class II (HDAC4, HDAC5, HDAC7 and HDAC9) and class IV (HDAC11). HDAC inhibitors, a large group of compounds that is able to induce the accumulation of acetylated histones as well as non-histone proteins, are divided into several structural classes including hydroxamates, cyclic peptides, aliphatic acids and benzamides. HDAC inhibitors have been investigated for their efficacy as anticancer agents in the treatment of a wild range of cancers.
HDAC 相关产品(200)
- GC14016SulforaphaneCAS: 4478-93-7纯度: >98.00% / >99.00% / >97.00%
萝卜硫素 (SFN) 称为 [1-isothiocyanato-4-(methylsulfinyl)butane]。
- GC14439Santacruzamate A (CAY10683)CAS: 1477949-42-0纯度: >99.00%
Santacruzamate A (CAY10683)是一种天然氨基甲酸酯衍生物,可抑制HDAC2和HDAC6活性,IC 50 值分别为0.119nM和434nM。
- GC14597ITSA-1 (ITSA1)CAS: 200626-61-5纯度: >98.00%
ITSA-1 (ITSA1)是一种组蛋白去乙酰化酶(HDAC)激活剂,可以防止动脉层流剪切力诱导的内皮细胞脱落,并降低血管内皮细胞(vECs)中VCAM-1的表达。
- GC18915Trapoxin ACAS: 133155-89-2
Trapoxin A is a cyclotetrapeptide histone deacetylase (HDAC) inhibitor.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12074 | BG45 | 926259-99-6 | >99.50% | |
A selective HDAC3 inhibitor | ||||
| GC12115 | CUDC-907 | 1339928-25-4 | >99.50% | |
CUDC 是一种口服生物可利用的小分子 PI3K 和 HDAC 双重抑制剂,作用于 PI3K α 和 HDAC1 / 2 / 3 / 10,IC50 分别为 19 nm 和 1.7 nm / 5 nm / 1.8 nm / 2.8 nm .在 WSU DLCL2 细胞中评估了双功能 HDAC 和 PI3K 抑制剂 CUDC-907 的抗肿瘤活性。 | ||||
| GC12484 | BRD73954 | 1440209-96-0 | >98.00% | |
A dual inhibitor of HDAC6 and HDAC8 | ||||
| GC12822 | BML-210(CAY10433) | 537034-17-6 | - | |
A potent, synthetic HDAC inhibitor | ||||
| GC12971 | CAY10603 | 1045792-66-2 | >99.50% | |
An exceptionally potent inhibitor of HDAC6 | ||||
| GC12976 | Suberohydroxamic Acid | 38937-66-5 | - | |
HDAC inhibitor | ||||
| GC13088 | BRD6688 | 1404562-17-9 | - | |
A kinetically selective HDAC2 inhibitor | ||||
| GC13435 | KD 5170 | 940943-37-3 | - | |
An inhibitor of class I and II HDACs | ||||
| GC13706 | Droxinostat | 99873-43-5 | >99.50% | |
An inhibitor of HDAC3, HDAC6, and HDAC8 | ||||
| GC14016 | Sulforaphane | 4478-93-7 | >98.00% / >99.00% / >97.00% | |
萝卜硫素 (SFN) 称为 [1-isothiocyanato-4-(methylsulfinyl)butane]。 | ||||
| GC14285 | RGFP966 | 1357389-11-7 | >99.50% / >98.00% | |
RGFP966是一种N-(o-aminophenyl)carboxamide HDAC抑制剂,对HDAC3的IC50为0.08 μM,是一类针对HDAC3的慢开/慢关竞争性紧密结合抑制剂。 | ||||
| GC14367 | UF 010 | 537672-41-6 | >99.50% | |
A class I HDAC inhibitor | ||||
| GC14439 | Santacruzamate A (CAY10683) | 1477949-42-0 | >99.00% | |
Santacruzamate A (CAY10683)是一种天然氨基甲酸酯衍生物,可抑制HDAC2和HDAC6活性,IC 50 值分别为0.119nM和434nM。 | ||||
| GC14597 | ITSA-1 (ITSA1) | 200626-61-5 | >98.00% | |
ITSA-1 (ITSA1)是一种组蛋白去乙酰化酶(HDAC)激活剂,可以防止动脉层流剪切力诱导的内皮细胞脱落,并降低血管内皮细胞(vECs)中VCAM-1的表达。 | ||||
| GC14998 | Rocilinostat (ACY-1215) | 1316214-52-4 | >98.00% | |
A selective inhibitor of HDAC6 | ||||
| GC15410 | Bufexamac | 2438-72-4 | >98.00% | |
An NSAID and a class IIb HDAC inhibitor | ||||
| GC15857 | Sodium butyrate | 156-54-7 | >99.00% | |
A short-chain fatty acid and HDAC inhibitor | ||||
| GC17005 | 4-iodo-SAHA | 1219807-87-0 | - | |
A potent SAHA analog | ||||
| GC17472 | Oxamflatin | 151720-43-3 | >98.00% | |
Inhibitor of histone deacetylases | ||||
| GC17703 | TMP269 | 1314890-29-3 | >98.00% | |
A selective class IIa HDAC inhibitor | ||||
| GC18206 | WT161 | 1206731-57-8 | >98.50% | |
A potent inhibitor of HDAC6 | ||||
| GC18402 | GSK3117391 | 1018673-42-1 | >98.50% | |
An HDAC inhibitor | ||||
| GC18915 | Trapoxin A | 133155-89-2 | - | |
Trapoxin A is a cyclotetrapeptide histone deacetylase (HDAC) inhibitor. | ||||
| GC19020 | ACY-738 | 1375465-91-0 | >98.50% | |
ACY-738是一种具有口服活性的选择性组蛋白去乙酰化酶6(HDAC6;IC 50 =1.7nM)抑制剂。 | ||||
